← FDA DRUG APPROVALS

FDA NDA · NDA215721

ZOLPIDEM TARTRATE

Sponsor: ALMATICA

APPLICATION
NDA215721
TYPE
NDA
ORIGINAL APPROVAL
2023-05-09
LATEST ACTION
2023-05-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ZOLPIDEM TARTRATE · ReferencePrescription
ZOLPIDEM TARTRATE 7.5MG · CAPSULE · ORAL

Approval history

2023-05-09Type 3 - New Dosage Form · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →